Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Booms, Busts, and Recoveries -- Ignore unavailable to you. Want to Upgrade?

To: Spheres who wrote (55758)	11/8/2004 5:26:24 PM
From: Biomaven	Read Replies (2) \| Respond to of 74559

Would a $200 Million/year grant to Celera Diagnostics change your mind? Not really. ABI currently has revenues of something like $2 billion and Celera Genomics revenues around $1 billion. So as a percentage it isn't huge, even assuming they got the whole contract, which is pretty unlikely the way these things usually work. Further, this isn't really what Celera Diagnostics does - they are trying to move up the food chain. This isn't an area I follow or know much about - I'm just speaking on general principles here. Peter